<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Taylor Karstensen | Activity</title>
	<link>https://toxicdolls.com/members/coffeeguitar22/activity/</link>
	<atom:link href="https://toxicdolls.com/members/coffeeguitar22/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Taylor Karstensen.</description>
	<lastBuildDate>Mon, 04 May 2026 08:35:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">2d54b70934aa88f642573b64ddd55dc6</guid>
				<title>Taylor Karstensen posted an update: These results imply that Tsf1 knockdown in the CNS could [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/7507/</link>
				<pubDate>Sun, 22 Jun 2025 11:51:02 +0000</pubDate>

									<content:encoded><![CDATA[<p>These results imply that Tsf1 knockdown in the CNS could attenuate rotenone toxicity by decreasing the ROS levels in brains through reducing iron levels, and manipulation of iron transporters in brains may provide a novel therapeutic strategy for sporadic PD.Flupirtine is a non-opioid centrally acting analgesic that has been in clinical use, and&hellip;<span class="activity-read-more" id="activity-read-more-7507"><a href="https://toxicdolls.com/activity-2/p/7507/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d81cc099e5799df1317584db546dab03</guid>
				<title>Taylor Karstensen posted an update: The purpose was to examine associations between treatment and [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/6466/</link>
				<pubDate>Sat, 21 Jun 2025 11:52:06 +0000</pubDate>

									<content:encoded><![CDATA[<p>The purpose was to examine associations between treatment and chronic health conditions with neurocognitive impairment survivors of acute lymphoblastic leukemia (ALL) treated with chemotherapy only.</p>
<p> This cross-sectional study included 1,207 ALL survivors (54.0% female; mean age 30.6 years) and 2,273 siblings (56.9% female; mean age 47.6&hellip;<span class="activity-read-more" id="activity-read-more-6466"><a href="https://toxicdolls.com/activity-2/p/6466/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bb52f0b542e90681a24d6b4cb39e9e38</guid>
				<title>Taylor Karstensen posted an update: There were no dislocations within 90 days of revision s [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/5777/</link>
				<pubDate>Fri, 20 Jun 2025 18:44:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>There were no dislocations within 90 days of revision surgery. 4 patients had late dislocations (3 recurrent, 1 isolated). There was no significant increase risk of dislocation after revision surgery in the neck of femur group (p = 0.467). CONCLUSIONS We report favourable outcomes for revision of both components for recurrent dislocation with&hellip;<span class="activity-read-more" id="activity-read-more-5777"><a href="https://toxicdolls.com/activity-2/p/5777/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">603cad4361c0e2992608a38a7922b3dc</guid>
				<title>Taylor Karstensen became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/5719/</link>
				<pubDate>Fri, 20 Jun 2025 18:03:43 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>